---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-021099"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-14T23:53:32.275779+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics to close business combination with Applied Digital, PIPE $15.75M, ticker becomes CHRN

## Summary
- Business combination with Applied Digital subsidiary closes May 5, 2026; company renames to ChronoScale Corporation.
- Applied Digital (parent) buys 1,311,407 shares at $12.01/share in PIPE, gross proceeds ~$15.75M.
- New ticker symbol 'CHRN' on Nasdaq; CUSIP changes to 170924104.
- Lake Street Capital Markets serves as placement agent, receives 5% cash fee (~$0.75M).

## SEC filing metadata
- accession: 0001493152-26-021099
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021099/0001493152-26-021099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021099/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-021099
- JSON: https://secwatch.observer/filing/0001493152-26-021099.json
- Plain text: https://secwatch.observer/filing/0001493152-26-021099.txt

## Source-grounded claims
- claim_id: 70de4a6eb943f44a250035041a8c9a0770bcc49f
  claim: EKSO BIONICS HOLDINGS, INC. entered into Securities Purchase Agreement with Applied Parent valued at gross proceeds of approximately $15.75 million (effective 2026-05-01).
  evidence_excerpt: the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Applied Parent (the “APLD Parent PIPE Investment”), pursuant to which the Company agreed to sell and issue to Applied Parent 1,311,407 shares of Common Stock (the “Private Placement Shares”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226021099/0001493152-26-021099-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.